Novartis AG Archives - Equitypandit

Dr Reddy’s Lab Reportedly Plans to Acquire Novartis India, Both Shares Hit 52-week High

Chinmay BohraFebruary 19, 2024

by Chinmay BohraFebruary 19, 202403995

Shares of Novartis India and Dr Reddy’s Laboratories hit fresh 52-week highs after reports surfaced suggesting that Dr Reddy’s plans to acquire Switzerland-based pharma company...

BUSINESS

Novartis to Prioritise US Market, Says CEO

Aniruddh ShrivastavaSeptember 22, 2022September 22, 2022

by Aniruddh ShrivastavaSeptember 22, 2022September 22, 202202600

Novartis, the Swiss pharma giant, said it would make the United States its top geographic priority, even after laws were passed to rein in drug...

BUSINESS

Novartis Intends to Separate Sandoz Business to Create Standalone Company

Aniruddh ShrivastavaAugust 25, 2022August 25, 2022

by Aniruddh ShrivastavaAugust 25, 2022August 25, 202201507

On Thursday, Novartis announced its intent to separate its generics and biosimilars division, Sandoz, into a new publicly traded standalone company by way of a...

BUSINESS

SoftBank Lead $80 Mn Funding Round in Pear Therapeutics

Neha VermaDecember 14, 2020December 16, 2020

by Neha VermaDecember 14, 2020December 16, 202001096

SoftBank Group’s Vision Fund 2 led an $80 million funding in Pear Therapeutics Inc., a leader in Prescription Digital Therapeutics. The Boston, Massachusetts-based startup develops prescription software...

Aurobindo Pharma To Buy Parts Of Sandoz US

adminSeptember 6, 2018

by adminSeptember 6, 201801333

The Swiss drugmaker, Novartis AG, said in a statement to the press that it would sell the dermatology and generic US oral solids portfolios of...

EquityPandit

Tag : Novartis AG

Dr Reddy’s Lab Reportedly Plans to Acquire Novartis India, Both Shares Hit 52-week High

Novartis to Prioritise US Market, Says CEO

Novartis Intends to Separate Sandoz Business to Create Standalone Company

SoftBank Lead $80 Mn Funding Round in Pear Therapeutics

Aurobindo Pharma To Buy Parts Of Sandoz US

EquityPandit